COMMUNIQUÉS West-GlobeNewswire

Serina Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
13/08/2026
Enrollment and dosing completed in Cohort 1 of Phase 1b registrational study of SER-252 - Top-line data from the single-ascending-dose arm targeted for the first half of 2027 - Appointment of Farrell Simon, Pharm.D., to [...]
Elutia Secures Up to $26 Million to Fund NXT-41x Through Commercial Launch; Reports Second Quarter 2026 Results
13/08/2026
Independent Blinded Survey of 50 Plastic Surgeons Validates Demand; NXT-41 and NXT-41x Remain On-Track Funded through launch: secured up to $26 million of capital without an equity offering The unmet need is real: 86% [...]
Celcuity Inc. Reports Release of Second Quarter 2026 Financial Results and Provides Corporate Update
13/08/2026
REVTORPYK™ (gedatolisib) approved by the U.S. FDA for the treatment of HR+/HER2- PIK3CA Wild-Type locally advanced or metastatic breast cancer on July 14, 2026; on track for commercial launch late third quarter 2026 [...]
Invivyd Reports Second Quarter 2026 Financial Results and Recent Business Highlights
13/08/2026
Achieved Q2 2026 PEMGARDA ® (pemivibart) net product revenue of $14.3 million, representing 21% growth versus Q2 2025 net product revenue of $11.8 million Completed rapid enrollment in VYD2311 DECLARATION clinical trial [...]
Mineralys Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
13/08/2026
RADNOR, Pa., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in [...]
Glass House Brands Reports Second Quarter 2026 Financial Results
13/08/2026
Second quarter results include record biomass production of 246,000 pounds and cost of production of $122 per pound, significant quarter-over-quarter improvements Company completed deconsolidation of its dual-use [...]
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13/08/2026
BEDFORD, Mass., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina experience, today [...]
Eledon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Business Highlights
13/08/2026
Successful End-of-Phase 2 meeting with FDA supports advancement of tegoprubart into a global Phase 3 kidney transplantation trial, on track to initiate in late 2026 Long-term Phase 2 BESTOW data presented at ATC 2026 [...]
Sanofi: Information concerning the total number of voting rights and shares - July 2026
13/08/2026
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Juillet 2026
13/08/2026
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
City of Mobile proclaims Project Persevere Day as The Helios Alliance Reports 117,444 Services Delivered in First Year of Opioid Abatement Program
13/08/2026
Sixteen organizations delivered 117,444 services at $143.81 per person — among the most efficient deployments of opioid settlement funds nationally — as a public awareness campaign prepares to launch Mobile, ALABAMA, [...]
Aligned Marketplace Raises $20 Million, Achieves Measurable Outcomes with Large Employers
13/08/2026
A Third-Party Validated 12 Percent Reduction in Total Cost of Care Delivered in Year One For A Large Fortune 500 Company Proves the Independent Primary Care Model Works at Scale NEW YORK, Aug. 13, 2026 (GLOBE NEWSWIRE [...]
Valneva Half-Year 2026 Financial Report
13/08/2026
Valneva Half-Year 2026 Financial Report Attachment Financial Report HY1 2026 (EN) (2026-08-12) (002)
Rapport Semestriel 2026 Valneva
13/08/2026
Rapport Semestriel 2026 Valneva Pièce jointe Financial Report HY1 2026 (FR) (2026-08-12) (002)
WellBridge Surgical Named No. 988 on the 2026 Inc. 5000 List, the Most Prestigious Ranking of America’s Fastest-Growing Private Companies
13/08/2026
Following Significant Revenue Growth Over the Past Three Years, Earning a Place Among the Nation’s Most Successful Independent Businesses INDIANAPOLIS, Aug. 13, 2026 (GLOBE NEWSWIRE) -- WellBridge Surgical today [...]
Tiny Health Named No. 208 on the 2026 Inc. 5000 List of America’s Fastest-Growing Private Companies
13/08/2026
Microbiome Innovator Recognized for 1,624% Three-Year Revenue Growth, Earning a Place Among the Nation’s Most Successful Independent Businesses AUSTIN, Texas, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Tiny Health , the [...]
Invitation to the presentation of ALK’s first six months (Q2) 2026 results on Thursday, 20 August 2026
13/08/2026
ALK (ALKB:DC / Nasdaq Copenhagen: ALK B) will publish its results for the first six months of 2026 in the morning on Thursday, 20 August 2026. Later on the same day, the company will host a presentation for investors [...]
Early-Bird Deadline Approaches for 2nd Annual Guardian Initiative Charity Golf Tournament as Veterans Seek Sponsors to Play
13/08/2026
Players have until August 28 to take advantage of early-bird pricing for the September 28 charity tournament at Maderas Golf Club, while local veterans are seeking sponsors for the opportunity to participate. San Diego [...]
Arisan Therapeutics Selected for NIAID Contract Award to Develop a Therapeutic Small Molecule Viral Entry Inhibitor as a Medical Countermeasure for Filovirus Infection
13/08/2026
Contract Valued at Up to $24 million Supports IND-Enabling Studies for Arisan’s Lead Candidate with Demonstrated Activity Against Multiple Ebolaviruses CARLSBAD, Calif., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Arisan [...]

Pages